Paul Riser Jr.

Paul Riser Jr. serves as managing director of technology-based entrepreneurship at TechTown Detroit, guiding the design, execution, and ongoing management of the nonprofit’s technology programming for early and seed stage companies. Riser is also the president and CEO of the Riser Group, a Northville, MI-based IT and business development consulting firm.

Recent posts

Detroit Trends in 2018? More Traction, Diversity, and Collaboration
Editor’s note: This is part of a series of posts sharing thoughts from industry and technology leaders about 2018 trends.
A few trends come to mind that continue to... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
What to Include in Your Life Sciences Company Fundraising Pitch Deck
What the most successful life sciences fundraising pitch decks all have in common
Brex

Sponsored · Whitepaper
How to Approach Life Sciences Fundraising
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
Brex

Sponsored · Whitepaper
How Big Is the US Market for Medical Devices & Technologies?
Knowing the volume of procedures and growth trends by site of care can allow you to understand the market demand for your product
IBM Watson

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy National

Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More

Tapping Into the Innovation Grid: J&J, Data, and a Shifting Healthcare Focus

VenBio Partners Bags $394M to Back More Medicine-Making Biotechs

As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

Zentalis Upsizes IPO, Raising $165M for Cancer Drug Clinical Trials

A Baby’s Milestones and the Next Steps for Novartis in Gene Therapy

Aspen Neuro Adds $70M to Test Parkinson’s Cell Therapy in the Clinic

With $80M, ReCode Looks to Advance RNA Therapies for Lung Diseases

As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

The Benefits and Impact of Later In-Licensing Deals for Biopharma

Tapping Into the Innovation Grid: J&J, Data, and a Shifting Healthcare Focus

Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More

Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More

Xcelerating Life Sciences Boston (interactive online event)

Xcelerating Life Sciences Philadelphia (interactive online event)

Xcelerating Life Sciences San Francisco (interactive online event)

Paul Riser Jr.

Recent posts

Detroit Trends in 2018? More Traction, Diversity, and Collaboration

Underwriters and Partners

What to Include in Your Life Sciences Company Fundraising Pitch Deck

How to Approach Life Sciences Fundraising

How Big Is the US Market for Medical Devices & Technologies?

Xconomy on Demand

We offer a number of ways to subscribe for free!